Comparison of the anti-diabetic effects
✍
Nigel Irwin; Paula L. McClean; Roslyn S. Cassidy; Finbarr P. M. O'Harte; Brian D
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 153 KB
## Abstract ## Background The two major incretin hormones, glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are being actively explored as anti‐diabetic agents because they lower blood glucose through multiple mechanisms. The rapid inactivation of GIP and GLP‐